MetaADEDB 2.0 @ LMMD
Podophyllotoxin
(YJGVMLPVUAXIQN-XVVDYKMHSA-N)
Structure
SMILES
COc1cc(cc(c1OC)OC)[C@H]1[C@H]2C(=O)OC[C@@H]2[C@H](c2c1cc1OCOc1c2)O
Type(s)
Approved
ATC code(s)
D06BB04
Molecular Formula:
C22H22O8
Molecular Weight:
414.405
Log P:
2.4092
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
1
TPSA:
92.68
CAS Number(s):
518-28-5; 4354-76-1
Synonym(s)
1.
Podophyllotoxin
2.
Epipodophyllotoxin
3.
CPH86
4.
Condyline
5.
Condylox
6.
Podocon-25
7.
Podofilm
8.
Podofilox
9.
Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer
10.
Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-Isomer
11.
Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer
12.
Podophyllotoxin, (5R-(5 alpha,5a beta,8a alpha,9 beta))-Isomer
13.
Wartec
14.
Warticon
External Link(s)
MeSHD011034
PubChem Compound10607
BindingDB50035218
ChEBI50305
CHEMBLCHEMBL61
DrugBankDB01179
DrugCentral3481
KEGGcpd:C10874
dr:D05529
Therapeutic Target DatabaseD0D4HN
D0SK5B
ZINC3861806
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
2Application site painFAERS: 3SIDER
US FAERS
3Application site burnFAERS: 2US FAERS
4Application site erythemaFAERS: 2US FAERS
5PainFAERS: 2SIDER
US FAERS
6VomitingFAERS: 2SIDER
US FAERS
7Accidental exposureFAERS: 1US FAERS
8Application site pruritusFAERS: 1US FAERS
9Application site urticariaFAERS: 1US FAERS
10AstheniaFAERS: 1US FAERS
11CystitisFAERS: 1US FAERS
12Depressed Level of ConsciousnessFAERS: 1US FAERS
13Drug administration errorFAERS: 1US FAERS
14Drug toxicityFAERS: 1US FAERS
15HyperventilationFAERS: 1US FAERS
16HyporeflexiaFAERS: 1US FAERS
17Incorrect drug administration durationFAERS: 1US FAERS
18MalaiseFAERS: 1US FAERS
19Product use complaintFAERS: 1US FAERS
20PruritusFAERS: 1SIDER
US FAERS
21QuadriparesisFAERS: 1US FAERS
22Respiratory FailureFAERS: 1US FAERS
23Status EpilepticusFAERS: 1US FAERS
24Urinary tract infectionFAERS: 1US FAERS
25UrticariaFAERS: 1US FAERS
26Application site hypersensitivitySIDER
27Application site irritationSIDER
28BalanoposthitisSIDER
29Carcinoma, Transitional Cell813346CTD
30Caustic injurySIDER
31Chemical injurySIDER
32Condylomata Acuminata9449907CTD
33DermatitisSIDER
34DizzinessSIDER
35Dry skinSIDER
36ErythemaSIDER
37ExcoriationSIDER
38HeadacheSIDER
39InflammationSIDER
40Instillation site painSIDER
41Peripheral Nervous System Diseases10965167CTD
42RednessSIDER
43ScabSIDER
44Sensation Disorders10965167CTD
45Skin ErosionSIDER
46Skin PapillomaSIDER
47Skin UlcerSIDER
48SwellingSIDER
49UlcerSIDER
50WartsSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.